Newsroom | NeoGenomics Laboratories

August 9, 2022

NeoGenomics Reports Revenue of $125 Million in the Second Quarter

Press Release

July 21, 2022

NeoGenomics Announces Chief Executive Officer Appointment

Press Release

July 15, 2022

NeoGenomics Schedules its Second Quarter 2022 Earnings Release for August 9, 2022

Press Release

July 15, 2022

Orphan CDx assays

Blog

July 6, 2022

MultiOmyx 101: An Introduction to Multiplexing Technology

Blog

July 4, 2022

Comprehensive Genomic Profiling (CGP) expands precision medicine’s utility

Blog

June 21, 2022

NeoGenomics Liquid Biopsy Subsidiary Inivata Announces New Data Demonstrating Clinical Potential of the RaDaR(TM) MRD Test in HR+ HER2- Breast Cancer

Press Release

June 4, 2022

NeoGenomics will be exhibiting at the 2022 ASCO Annual Meeting from June 4 – 6

Blog

Fact Sheets

Company Overview

Diagnostic Services

Pharma Services

Contact Us To Get Started!

Work with us – your premier oncology partner – to optimize cancer care for patients